About
Klaus joined +ND Capital's Lausanne office in 2021 after 18 years in the pharmaceutical industry, including over 8 years as Chief Medical Officer at Boehringer Ingelheim. He is currently CEO of Vandria.
Colleagues at +ND Capital
Alison Palmer
Vice President of the General Partner at +ND Capital
André Châtelain
Advisor at +ND Capital
Aymeric Sallin
Founder and CEO at +ND Capital
Carl Pabo
Advisor at +ND Capital
Cathleen O’Connor
Executive Assistant at +ND Capital
Eric Moessinger
Partner at +ND Capital
Gabriela Ecco
Principal at +ND Capital
Jonathan Nicholson
Executive Director of the General Partner at +ND Capital